Compounds > fluorobenzenes
Page last updated: 2024-08-21

fluorobenzenes and Reperfusion Injury

fluorobenzenes has been researched along with Reperfusion Injury in 17 studies

Research

Studies (17)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (29.41)29.6817
2010's12 (70.59)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hasegawa, Y; Kataoka, K; Katayama, T; Kim-Mitsuyama, S; Koibuchi, N; Kuratsu, J; Ma, M; Nakagawa, T; Sueta, D; Toyama, K; Uekawa, K1
Caliskan, A; Demirtas, S; Guclu, O; Karahan, O; Mavitas, B; Yavuz, C; Yazici, S1
Chen, C; Dai, R; Lin, R; Su, Z; Wu, B; Wu, H1
Beeson, CC; Garrett, SM; Schnellmann, RG; Whitaker, RM1
Adachi, O; Fukushige, S; Horii, A; Kawamoto, S; Matsuo, S; Saiki, Y1
Maeda, K; Ruel, M1
Boerman, OC; Dekker, D; Meijer, P; Oyen, WJ; Rongen, GA; Scheffer, GJ; Smits, P; van den Broek, PH; Wouters, CW1
Akgür, FM; Ateş, O; Karakaya, E; Olguner, M1
Awad, AS; El Sharif, A1
Gori, T; Liuni, A; Luca, MC; Parker, JD2
Arslan, S; Güler, A; Kılıçkaya, O; Onan, B; Oztaş, E; Sahin, MA; Ucak, A; Uysal, B; Yılmaz, AT1
Bronckers, I; Hopman, MT; Rongen, GA; Smits, P; Thijssen, DH; Wever, KE; Wouters, CW1
Handa, O; Ichikawa, H; Katada, K; Kokura, S; Kuroda, M; Naito, Y; Takagi, T; Tsuboi, H; Yoshida, N; Yoshikawa, T1
Doerfler, A; Engelhorn, T; Heusch, G; Schulz, R1
Balkaya, M; Endres, M; Gertz, K; Kronenberg, G; Laufs, U; Leithner, C; Lindauer, U; Prinz, V1
Böhm, M; Dirnagl, U; Endres, M; Gertz, K; Laufs, U; Nickenig, G1

Trials

3 trial(s) available for fluorobenzenes and Reperfusion Injury

ArticleYear
Rosuvastatin increases extracellular adenosine formation in humans in vivo: a new perspective on cardiovascular protection.
    Arteriosclerosis, thrombosis, and vascular biology, 2009, Volume: 29, Issue:6

    Topics: Adenosine; Administration, Oral; Annexin A5; Caffeine; Dipyridamole; Dose-Response Relationship, Drug; Double-Blind Method; Female; Fluorobenzenes; Forearm; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Infusions, Intra-Arterial; Male; Nitroprusside; Pyrimidines; Radionuclide Imaging; Regional Blood Flow; Reperfusion Injury; Rosuvastatin Calcium; Sulfonamides; Time Factors; Up-Regulation; Vasodilation; Vasodilator Agents

2009
Short-term statin treatment does not prevent ischemia and reperfusion-induced endothelial dysfunction in humans.
    Journal of cardiovascular pharmacology, 2012, Volume: 59, Issue:1

    Topics: 5'-Nucleotidase; Adolescent; Adult; Atorvastatin; Blood Pressure; Brachial Artery; Dose-Response Relationship, Drug; Double-Blind Method; Endothelium, Vascular; Female; Fluorobenzenes; Heart Rate; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipids; Male; Middle Aged; Pyrimidines; Pyrroles; Real-Time Polymerase Chain Reaction; Reperfusion Injury; Rosuvastatin Calcium; Sulfonamides; Time Factors; Vasodilation; Young Adult

2012
Loss of the preconditioning effect of rosuvastatin during sustained therapy: a human in vivo study.
    American journal of physiology. Heart and circulatory physiology, 2012, Jan-01, Volume: 302, Issue:1

    Topics: Adolescent; Adult; Analysis of Variance; Blood Flow Velocity; Celecoxib; Cyclooxygenase 2 Inhibitors; Double-Blind Method; Drug Administration Schedule; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperemia; Ischemia; Male; Ontario; Pyrazoles; Pyrimidines; Radial Artery; Regional Blood Flow; Reperfusion Injury; Rosuvastatin Calcium; Sulfonamides; Time Factors; Vasodilation; Young Adult

2012

Other Studies

14 other study(ies) available for fluorobenzenes and Reperfusion Injury

ArticleYear
Pretreatment with rosuvastatin protects against focal cerebral ischemia/reperfusion injury in rats through attenuation of oxidative stress and inflammation.
    Brain research, 2013, Jun-26, Volume: 1519

    Topics: Animals; Brain Infarction; Brain Ischemia; Calcium-Binding Proteins; Cyclooxygenase 2; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Ectodysplasins; Encephalitis; Fluorobenzenes; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Membrane Glycoproteins; Microfilament Proteins; NADPH Oxidase 2; NADPH Oxidases; NF-kappa B; Nitric Oxide Synthase Type II; Oxidative Stress; Pyrimidines; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Rosuvastatin Calcium; Sulfonamides; Up-Regulation

2013
Rosuvastatin may have neuroprotective effect on spinal cord ischemia reperfusion injury.
    CNS & neurological disorders drug targets, 2013, Volume: 12, Issue:7

    Topics: Animals; Antioxidants; Biomarkers; Fluorobenzenes; Male; Nerve Degeneration; Neuroprotective Agents; Pyrimidines; Rats; Reactive Oxygen Species; Reperfusion Injury; Rosuvastatin Calcium; Spinal Cord; Spinal Cord Injuries; Sulfonamides

2013
Short-time pretreatment of rosuvastatin attenuates myocardial ischemia and reperfusion injury by inhibiting high mobility group box 1 protein expression.
    International journal of cardiology, 2013, Oct-12, Volume: 168, Issue:5

    Topics: Animals; Biomarkers; Fluorobenzenes; HMGB1 Protein; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Malondialdehyde; Myocardial Ischemia; Oxidative Stress; Premedication; Pyrimidines; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Rosuvastatin Calcium; Sulfonamides; Superoxide Dismutase

2013
Agonism of the 5-hydroxytryptamine 1F receptor promotes mitochondrial biogenesis and recovery from acute kidney injury.
    The Journal of pharmacology and experimental therapeutics, 2014, Volume: 350, Issue:2

    Topics: Acute Kidney Injury; Animals; Benzamides; Carbazoles; DNA, Mitochondrial; Electron Transport Complex IV; Female; Fluorobenzenes; Indoles; Kidney; Male; Mice; Mice, Inbred C57BL; Mitochondria; Oxidative Phosphorylation; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Rabbits; Receptor, Serotonin, 5-HT1F; Receptors, Serotonin; Reperfusion Injury; Serotonin Receptor Agonists; Transcription Factors

2014
Single-dose rosuvastatin ameliorates lung ischemia-reperfusion injury via upregulation of endothelial nitric oxide synthase and inhibition of macrophage infiltration in rats with pulmonary hypertension.
    The Journal of thoracic and cardiovascular surgery, 2015, Volume: 149, Issue:3

    Topics: Animals; Anti-Inflammatory Agents; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Disease Models, Animal; Endothelium, Vascular; Fluorobenzenes; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension, Pulmonary; Lung; Lung Injury; Macrophages; Male; Mevalonic Acid; Monocrotaline; Nitric Oxide Synthase Type III; Oxygen; Phosphorylation; Pulmonary Edema; Pyrimidines; Rats, Sprague-Dawley; Reperfusion Injury; Rosuvastatin Calcium; Sulfonamides; Up-Regulation

2015
Prevention of ischemia-reperfusion injury in cardiac surgery: therapeutic strategies targeting signaling pathways.
    The Journal of thoracic and cardiovascular surgery, 2015, Volume: 149, Issue:3

    Topics: Animals; Anti-Inflammatory Agents; Endothelium, Vascular; Fluorobenzenes; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension, Pulmonary; Lung; Lung Injury; Macrophages; Male; Nitric Oxide Synthase Type III; Pyrimidines; Reperfusion Injury; Rosuvastatin Calcium; Sulfonamides

2015
Rosuvastatin protects tissue perfusion in the experimental testicular torsion model.
    International urology and nephrology, 2010, Volume: 42, Issue:2

    Topics: Animals; Disease Models, Animal; Fluorobenzenes; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Pyrimidines; Rats; Rats, Wistar; Reperfusion Injury; Rosuvastatin Calcium; Spermatic Cord Torsion; Sulfonamides

2010
Immunomodulatory effects of rosuvastatin on hepatic ischemia/reperfusion induced injury.
    Immunopharmacology and immunotoxicology, 2010, Volume: 32, Issue:4

    Topics: Animals; Blood; Chemokine CCL2; Fluorobenzenes; Heart; Immunologic Factors; Interleukin-10; Interleukin-6; Intestinal Mucosa; Intestines; Kidney; Liver; Lung; Male; Multiple Organ Failure; Myocardium; Pyrimidines; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Rosuvastatin Calcium; Sulfonamides; Tumor Necrosis Factor-alpha

2010
The endothelial-protective effects of HMG-CoA reductase inhibition in the setting of ischemia and reperfusion injury.
    Clinical hemorheology and microcirculation, 2010, Volume: 45, Issue:2-4

    Topics: Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Endothelium, Vascular; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ischemia; Protective Agents; Pyrimidines; Reperfusion Injury; Rosuvastatin Calcium; Sulfonamides

2010
Rosuvastatin, a new generation 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor, reduces ischemia/reperfusion-induced spinal cord tissue injury in rats.
    Annals of vascular surgery, 2011, Volume: 25, Issue:5

    Topics: Analysis of Variance; Animals; Aorta, Abdominal; Cytoprotection; Disease Models, Animal; Fluorobenzenes; Glutathione Peroxidase; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Malondialdehyde; Motor Activity; Necrosis; Neurologic Examination; Neuroprotective Agents; Pyrimidines; Rats; Rats, Wistar; Reperfusion Injury; Rosuvastatin Calcium; Spinal Cord; Spinal Cord Injuries; Sulfonamides; Superoxide Dismutase; Time Factors

2011
Rosuvastatin reduces rat intestinal ischemia-reperfusion injury associated with the preservation of endothelial nitric oxide synthase protein.
    World journal of gastroenterology, 2006, Apr-07, Volume: 12, Issue:13

    Topics: Animals; Chemokine CXCL1; Chemokines, CXC; Fluorobenzenes; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intestines; Lipid Peroxidation; Male; Nitric Oxide Synthase Type III; Pyrimidines; Rats; Rats, Sprague-Dawley; Reperfusion Injury; RNA, Messenger; Rosuvastatin Calcium; Sulfonamides; Tumor Necrosis Factor-alpha

2006
Reduction of cerebral infarct size by the AT1-receptor blocker candesartan, the HMG-CoA reductase inhibitor rosuvastatin and their combination. An experimental study in rats.
    Neuroscience letters, 2006, Oct-02, Volume: 406, Issue:1-2

    Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Brain; Cerebral Infarction; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Enzyme Activation; Enzyme Inhibitors; Fluorobenzenes; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Infarction, Middle Cerebral Artery; Ischemic Attack, Transient; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type III; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Reperfusion Injury; Rosuvastatin Calcium; Sulfonamides; Tetrazoles; Treatment Outcome

2006
Intravenous rosuvastatin for acute stroke treatment: an animal study.
    Stroke, 2008, Volume: 39, Issue:2

    Topics: Acute Disease; Animals; Aorta; Disease Models, Animal; Dose-Response Relationship, Drug; Fluorobenzenes; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Infarction, Middle Cerebral Artery; Injections, Intravenous; Mice; Mice, Inbred Strains; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Phosphorylation; Proto-Oncogene Proteins c-akt; Pyrimidines; Recovery of Function; Reperfusion Injury; Rosuvastatin Calcium; Sulfonamides

2008
Rosuvastatin, a new HMG-CoA reductase inhibitor, upregulates endothelial nitric oxide synthase and protects from ischemic stroke in mice.
    Brain research, 2002, Jun-28, Volume: 942, Issue:1-2

    Topics: Animals; Brain Ischemia; Cells, Cultured; Cerebral Infarction; Cerebrovascular Circulation; Dose-Response Relationship, Drug; Endothelium, Vascular; Fluorobenzenes; Gene Expression Regulation, Enzymologic; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Infarction, Middle Cerebral Artery; Mice; Mice, Inbred Strains; Neuroprotective Agents; Nitric Oxide Synthase; Pyrimidines; Reperfusion Injury; RNA, Messenger; Rosuvastatin Calcium; Stroke; Sulfonamides; Up-Regulation

2002